The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression of PD-1 and PD-L1 in patients with renal cell carcinoma with sarcomatoid dedifferentiation (sRCC).
 
Fumi Kawakami
No Relationships to Disclose
 
Kanishka Sircar
No Relationships to Disclose
 
Jaime Rodriguez-Canales
No Relationships to Disclose
 
Pheroze Tamboli
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Pfizer
Travel, Accommodations, Expenses - Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Eric Jonasch
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Exelixis; GlaxoSmithKline; Novartis; Onyx; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Clovis Oncology; GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; Lilly; Lilly
Speakers' Bureau - Boehringer Ingelheim; Medscape; Pfizer
Research Funding - Bayer; Genentech; Jounce Therapeutics; Merck; Myriad Genetics; OncoPlex Diagnostics
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Jose A. Karam
No Relationships to Disclose